Introduction
Recently there has been a sharp reduction in the perinatal mortality rate associated with diabetes in pregnancy,1 2 
and
Hallamshire Hospital, Sheffield S10 9JF JONATHAN M POTTER, BM, MRCP, Novo research fellow in diabetes JOHN P D RECKLESS, MD, MRCP, senior registrar in general medicine and diabetes mellitus (now consultant physician, Royal United Hospital, Bath BAl 3NG) DEREK R CULLEN, MD, FRCP, consultant physician much evidence suggests that improved control of maternal blood glucose concentrations has been an important contributory factor.3 Pedersen suggested that closer supervision of the pregnancy, and particularly of the mother's diabetes, with prolonged inpatient management improved perinatal survival,5 and others have confirmed these findings., Karlsson and Kjellmer have presented evidence that mean daily blood glucose concentrations under 5 7 mmol/l (102-6 mg/100 ml) during the last trimester in pregnant diabetics are associated with a significant reduction in fetal mortality.7 There is still, however, an increased mortality and morbidity associated with diabetes in pregnancy with total perinatal mortality rates of 5%/ to 10% reported from major units' 2 and rates of 10%' to 20% among insulin-dependent mothers.7-9 The incidence of complications such as congenital malformations, respiratory distress, and neonatal hypoglycaemia is also increased in this group of neonates."0 Thus it is likely that further improvements in maternal glucose concentrations can still be achieved to give a further decline in perinatal mortality and morbidity.
In non-pregnant diabetics diurnal blood glucose concentrations can be improved using subcutaneous continuous insulin infusion, which has been used in outpatients."' 12 It seems particularly appropriate, therefore, to consider this method of insulin administration for pregnant diabetics in whom the best possible control is required over a limited time.
Patients and methods
Eight pregnant patients were studied. Table I shows their age, obstetric history, and insulin dose immediately before the start of the continuous infusion. These patients were classified using the White classification,'3 which is an index of the severity of diabetes determined by its duration, age at onset, and complications. Six of the patients were established insulin-requiring diabetics before pregnancy (cases 1, 2, 4, 6, 7, and 8) and two (cases 3 and 5) developed diabetes requiring treatment with insulin at the beginning of the third trimester.
During the first two trimesters the insulin-requiring patients were managed on a twice-daily insulin regimen (table I), and the insulin dose was altered according to a twice-weekly, four-point blood glucose profile (samples taken at 0700, 1100, 1500, and 2100) using an Ames Eyetone reflectance meter operated by the patient at home.
The same regimen was used for the patients developing diabetes during pregnancy once they required insulin. Each patient was admitted at 32 weeks' gestation and the insulin dose further adjusted to achieve blood glucose concentrations of 3-0-8-0 mmol/l (54-144 mg/100 ml) measured four times daily using the Ames Eyetone reflectance meter. Once optimal control of diabetes was achieved a 24-hour glucose profile was obtained from samples taken hourly through the day from 0800 until midnight and at 0200, 0400, 0600, and 0700. Patients were then started on continuous infusion, and control of diabetes was re-established. A further 24-hour profile was then obtained. The infusion was maintained throughout the rest of the pregnancy and throughout delivery.
A Pye Dynamic MS16 syringe driver (weight 227 g; size 16-5 cm x 8-0 cm x 2-8 cm) was used for insulin infusion. This was carried in a holster and allowed the patients to be freely ambulant. The syringe driver operated at 1-99 mm/h, which with disposable syringes delivered insulin at 0 33-263 units/h without the need to dilute the insulin. The rate of infusion was easily altered by a screw adjustment. The syringe-usually a 1-or 2-ml disposable syringe-was connected to a fine plastic catheter (Lectrocath 100 cm; bore 1 mm internal, 2 mm external) that was connected to an Argyle Medicut gauge 20 plastic cannula sited subcutaneously in the upper arm. The cannula was held in place with tape, and the implantation site was protected by gauze and a Netalast bandage. Patients were taught to refill the syringe with insulin and to change the infusion rate over mealtimes.
A basal infusion rate was delivered to the patient, which was augmented over mealtimes. The initial basal infusion rate was 0-66 units/h or 1-33 units/h depending on the insulin requirements of the patient. This was then adjusted to achieve fasting glucose concentrations of about 5-0 mmol/l (90 mg/100 ml). The augmented rates, given for one hour starting 30 minutes before the three main meals, were initially-ten times higher than the basal rate. More effective control of diabetes, however, was obtained with variable mealtime augmentation, and we subsequently gave initial augmented rates of half the total insulin requirement on the twice-daily insulin regimen minus the basal dose of insulin at breakfast and one-quarter of this amount over lunch and supper. Augmented rates were then adjusted to try to limit postprandial glucose increases to 8-0 mmol/l (144 mg/100 ml) or less. Short-acting insulins were used for infusions, the purity on continuous infusions being the same as on conventional regimens. 
M=X(10 log,0 BG/4-6)3/n where BG is the blood glucose concentration and n the number of glucose estimations.
Results
The pumps proved effective for insulin administration and maintained control of diabetes for 5-55 days without mechanical failure. The batteries powered the pumps satisfactorily for two weeks, when they were routinely changed. The syringes, catheters, and cannulas did not become disconnected, and there were no complications associated with the implantation site; in particular there was no evidence of infection or atrophy of the skin. The patients were able to alter the rate of infusion before and after meals and recharge the syringe with insulin without difficulty. The recharging procedure was straightforward, although care was needed to prevent air bubbles accumulating in the catheter. The patients were mobile and could wash, bathe, and sleep without hindrance. All the patients became interested in the technique and were keen to refill the syringe and alter the infusion rates themselves. Five patients were able to go home at weekends, where they maintained their infusions satisfactorily. Table II shows the infusion rates and doses of insulin. Basal infusion rates varied from 0-66 to 1-5 units/h. Although this was a narrow range, small changes in basal rate within this range had a considerable effect on fasting blood glucose concentrations. The augmented rates varied from 8 to 47 units/h. There was considerable variation in requirements between patients and in the same patient between meals. We found that better control of diabetes could be obtained with variable mealtime augmentation of the infusion rate, with more insulin always being required at breakfast than at other mealtimes. In one patient (case 5), who required insulin injections four times daily before continuous infusion, control was readily obtained with this pattern of variable mealtime augmentation on continuous infusion. Table III shows the control of blood glucose concentration on intermittent insulin regimens and on continuous infusion. The mean 24-hour blood glucose concentrations were similar on both regimens (62 mmol/I (111-6 mg/100 ml) on intermittent regimens; and 59 mmol/l (106 2 mg/100 ml) on continuous infusion). Fasting glucose concentrations tended to be higher on continuous infusion (6 2 mmol/l; 111-6 mg/100 ml) compared with intermittent regimens (5-3 mmol/l; 95 4 mg/100 ml), but the lower concentrations on intermittent regimens were associated with episodes of nocturnal hypoglycaemia in some patients. There was, however, a trend towards a reduction in the variation of blood glucose concentrations during the day on continuous infusion as shown by the lower standard deviation (2 5 v 2-0 mmol/l; 45 v 36 mg/100 ml) maximal excursion (8-4 v 7-4 mmol/l; 151 2 v 133 2 mg/100 ml), and M value (16 v 14).
Discussion
Since the increased perinatal mortality and morbidity associated with diabetes during pregnancy can be decreased by better maternal diabetic control,5 6 it is necessary to determine ways of improving this control. The development of portable open-loop systems for long-term insulin administration has considerably improved the control of blood glucose concentrations.17 Some of these systems infuse insulin intravenously,'8 but subcutaneous continuous insulin infusion with its comparatively safer route of administration presents attractive possibilities for use in pregnant diabetics. This system would be expected to give a more physiological supply of insulin than once-daily or twice-daily injections, since carbohydrate loads would be more effectively offset by individually adjusted mealtime augmentations of the infusion rates, and the postabsorptive states would be covered by a low but steady supply of insulin rather than the varying concentrations available on twice-daily injections. These benefits would be particularly useful in the management of pregnant diabetics, in whom the best possible control of blood glucose concentration is required for a limited time.
We have shown the infusion system used in this study to be practical and reliable. Neither the batteries nor the pump failed, and there were no problems with the connections between the pump and the implantation site. Furthermore, control of diabetes was sustained for long periods in individual patients, some of whom were also able to use the technique while at home during the weekend. Our With further development and use of this method of administration of insulin appreciable improvements in the control of diabetes may become apparent that could be beneficial in the management of pregnant diabetics during the third trimester. ONE HUNDRED YEARS AGO We read in the Times of a novel and startling addition to telegraphic possibilities, viz., "seeing by telegraph." By means of a lens, an image of the object is thrown upon a receiving plate. This is built up of a series of thermopile elements grooved anteriorly to an even surface, and connected by their posterior ends with a series of wires which transmit the electric currents generated by the reception of the image to a similar series of elements in a second plate at a distance. In this second plate, the electric currents create changes exactly corresponding to those produced by the image on the receiving plate. The close analogy between this apparatus and the rods and cones of the retina and the fibres of the optic nerve is obvious. (British Medical_Journal, 1880.) 
